CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE

All Clinical Trials for ETHOSUXIMIDE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	Children's Hospital Medical Center, Cincinnati	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University Health Center	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.

Clinical Trial Conditions for ETHOSUXIMIDE

Condition Name

Condition Name for ETHOSUXIMIDE
Intervention	Trials
Peripheral Neuropathic Pain	2
Epilepsy	2
Absence Epilepsy	1
Ketogenic Dieting	1

Condition MeSH

Condition MeSH for ETHOSUXIMIDE
Intervention	Trials
Epilepsy	4
Syndrome	3
Epilepsy, Absence	2
Irritable Bowel Syndrome	2

Clinical Trial Locations for ETHOSUXIMIDE

Trials by Country

Trials by Country for ETHOSUXIMIDE
Location	Trials
United States	24
France	4
United Kingdom	3
Egypt	2
China	1

Trials by US State

Trials by US State for ETHOSUXIMIDE
Location	Trials
Pennsylvania	2
Virginia	1
Illinois	1
Michigan	1
Missouri	1

Clinical Trial Progress for ETHOSUXIMIDE

Clinical Trial Phase

Clinical Trial Phase for ETHOSUXIMIDE
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	3
Phase 2	5

Clinical Trial Status

Clinical Trial Status for ETHOSUXIMIDE
Clinical Trial Phase	Trials
Recruiting	4
Unknown status	3
Completed	3

Clinical Trial Sponsors for ETHOSUXIMIDE

Sponsor Name

Sponsor Name for ETHOSUXIMIDE
Sponsor	Trials
University Hospital, Clermont-Ferrand	3
Great Ormond Street Hospital for Children NHS Foundation Trust	1
SFETD (Socièté Française d'Etude et de Traitement de la Douleur)	1

Sponsor Type

Sponsor Type for ETHOSUXIMIDE
Sponsor	Trials
Other	35
U.S. Fed	2
NIH	1